Maze Therapeutics Uses CRISPR to Identify Genetic Modifiers That Could Lead to Precision Medicine Companion Diagnostics for Clinical Laboratories

With $191 million in startup capital, the genomics startup will draw on existing genetic databases to create personalized medicine therapies for chronic diseases Why do some people get sick while others do not? That’s what genetic researchers at Maze Therapeutics want to find out. They have developed a new approach to using tools such as […]
Source: Dark Daily - Category: Laboratory Medicine Authors: Tags: Instruments & Equipment Laboratory Pathology Aaron Gitler PhD anatomic pathology ARCH Venture Partners C9O4F72 Charles Homcy MD clinical laboratory companion diagnostics CRISPR Dark Daily dark intelligence group Dark Report dipep Source Type: news